HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation

Published:2009-12-09 Issue:2 Volume:87 Page:223-235
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

del Rio M. L.,Lucas C. L.,Buhler L.,Rayat G.,Rodriguez-Barbosa J. I.

Funder

Fondo de Investigaciones Sanitarias

Consejeria de Educación

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1189/jlb.0809590/fullpdf

Reference95 articles.

1. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator;Cai;Nat. Immunol.,2008

2. Functional diversity of helper T lymphocytes;Abbas;Nature,1996

3. Diversity in CD8(+) T cell differentiation;Parish;Curr. Opin. Immunol.,2009

4. Plasticity of CD4+ T cell lineage differentiation;Zhou;Immunity,2009

5. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation;Salomon;Annu. Rev. Immunol.,2001

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression;Pharmaceuticals;2024-07-21

2. Human erythroid progenitors express antigen presentation machinery;2024-07-01

3. Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival;International Journal of Molecular Sciences;2024-06-22

4. The BTLA–HVEM axis restricts CAR T cell efficacy in cancer;Nature Immunology;2024-06

5. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3